Newsroom

One of only a handful of physicians with formal training in both vascular surgery and interventional radiology, Dr. Darren B. Schneider has been appointed chief of vascular and endovascular surgery and director of the Center for Vascular and Endovascular Surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. He has also been named associate professor of surgery at Weill Cornell Medical College.

Dr. Darren B. Schneider

"I am pleased to welcome Dr. Schneider to NewYork-Presbyterian/Weill Cornell. As one of the world's leaders in the minimally invasive surgical procedures, and an expert in vascular surgery, endovascular surgery and interventional radiology, he is uniquely qualified to lead our Center for Vascular and Endovascular Surgery and guide the development of innovative treatments for patients suffering from vascular disease," says Dr. Fabrizio Michelassi, chairman of the Department of Surgery and the Lewis Atterbury Stimson Professor of Surgery at Weill Cornell Medical College and surgeon-in-chief at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

Dr. Schneider is one of a select group of vascular surgeons also trained in interventional radiology, giving him the unique perspective and expertise to perform minimally invasive endovascular procedures for carotid disease, aortic aneurysms and dissections, and peripheral artery disease. He is also experienced in minimally invasive and open surgical approaches for treatment of varicose veins and deep vein thrombosis. And using the Hospital's new operating rooms with Artis zeego® medical imaging systems, he is also able to perform hybrid procedures that combine a catheter-based approach and open surgery to best meet the needs of each individual patient. One particular area of interest for Dr. Schneider is the development of new treatments for limb preservation for patients with advanced lower extremity vascular disease. "Early and aggressive vascular treatment appears to significantly reduce the risk of amputation in patients with inadequate circulation in the affected limb," he says. "Our cross-disciplinary approach will focus on early diagnosis, education, intervention, as well as unique, advanced endovascular techniques, and new bone marrow and stem cell therapies."

Dr. Schneider is also leading the development and design of innovative new devices for endovascular treatment of aortic aneurysms and arterial blockages. He is actively involved in clinical trials at NewYork-Presbyterian/Weill Cornell investigating stents and stent grafts designed for minimally invasive treatment of arterial aneurysms and blockages. He is also the national principal investigator directing several multicenter clinical trials of vascular devices.

Dr. Schneider received his B.S. degree from Stanford University and his M.D. from the University of California, San Diego. He completed his general surgery residency training at the University of California and a postdoctoral fellowship at the Gladstone Institute of Cardiovascular Surgery in San Francisco. Dr. Schneider also completed fellowships in interventional radiology and vascular surgery at the University of California, San Francisco. Prior to joining NewYork-Presbyterian/Weill Cornell, Dr. Schneider was associate professor of surgery and associate professor of radiology at the University of California, San Francisco.

Dr. Schneider is a member of many prestigious professional surgical organizations, including the Society for Vascular Surgery, the International Society of Endovascular Specialists, the Society of Interventional Radiology, the Association for Academic Surgery, the International Society for Vascular Surgery, the Society of University Surgeons and the Western Vascular Society. Dr. Schneider was also the president-elect and program chair of the Northern California Vascular Society. He has been selected by Castle Connolly as one of America's Best Doctors from 2005 to 2010 and was named one of America's Best Surgeons in 2008.

NewYork-Presbyterian Hospital/Weill Cornell Medical Center

NewYork-Presbyterian Hospital/Weill Cornell Medical Center, located in New York City, is one of the leading academic medical centers in the world, comprising the teaching hospital NewYork-Presbyterian and Weill Cornell Medical College, the medical school of Cornell University. NewYork-Presbyterian/Weill Cornell provides state-of-the-art inpatient, ambulatory and preventive care in all areas of medicine, and is committed to excellence in patient care, education, research and community service. Weill Cornell physician-scientists have been responsible for many medical advances — including the development of the Pap test for cervical cancer; the synthesis of penicillin; the first successful embryo-biopsy pregnancy and birth in the U.S.; the first clinical trial for gene therapy for Parkinson's disease; the first indication of bone marrow's critical role in tumor growth; and, most recently, the world's first successful use of deep brain stimulation to treat a minimally conscious brain-injured patient. NewYork-Presbyterian Hospital also comprises NewYork-Presbyterian Hospital/Columbia University Medical Center, NewYork-Presbyterian/Morgan Stanley Children's Hospital, NewYork-Presbyterian Hospital/Westchester Division and NewYork-Presbyterian/The Allen Hospital. NewYork-Presbyterian is the #1 hospital in the New York metropolitan area and is consistently ranked among the best academic medical institutions in the nation, according to U.S.News & World Report. Weill Cornell Medical College is the first U.S. medical college to offer a medical degree overseas and maintains a strong global presence in Austria, Brazil, Haiti, Tanzania, Turkey and Qatar. For more information, visit www.nyp.org and www.med.cornell.edu.